# Pilot Study of Preoperative Tarceva (Erlotinib) for Stages I/II Non-Small Cell Lung Cancer

> **NCT00385996** · PHASE2 · COMPLETED · sponsor: **Weill Medical College of Cornell University** · enrollment: 22 (actual)

## Conditions studied

- Carcinoma, Non-small Cell Lung

## Interventions

- **DRUG:** Tarceva (Erlotinib)

## Key facts

- **NCT ID:** NCT00385996
- **Lead sponsor:** Weill Medical College of Cornell University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-10
- **Primary completion:** 2008-11
- **Final completion:** 2011-08
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2018-12-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00385996

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00385996, "Pilot Study of Preoperative Tarceva (Erlotinib) for Stages I/II Non-Small Cell Lung Cancer". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT00385996. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*